BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8098781)

  • 1. Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.
    Martin S; Casasnovas JM; Staunton DE; Springer TA
    J Virol; 1993 Jun; 67(6):3561-8. PubMed ID: 8098781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful prevention of rhinovirus infections with chimeric ICAM-1 immunoglobulin in vitro].
    Martin S; Casanovas JM; Staunton DE; Springer TA
    Med Klin (Munich); 1993 Apr; 88(4):193-7. PubMed ID: 8098506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule.
    Crump CE; Arruda E; Hayden FG
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1425-7. PubMed ID: 7916558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.
    Greve JM; Forte CP; Marlor CW; Meyer AM; Hoover-Litty H; Wunderlich D; McClelland A
    J Virol; 1991 Nov; 65(11):6015-23. PubMed ID: 1681115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus.
    Staunton DE; Dustin ML; Erickson HP; Springer TA
    Cell; 1990 Apr; 61(2):243-54. PubMed ID: 1970514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand.
    Bella J; Kolatkar PR; Marlor CW; Greve JM; Rossmann MG
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4140-5. PubMed ID: 9539703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding.
    Register RB; Uncapher CR; Naylor AM; Lineberger DW; Colonno RJ
    J Virol; 1991 Dec; 65(12):6589-96. PubMed ID: 1719231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.
    Hoover-Litty H; Greve JM
    J Virol; 1993 Jan; 67(1):390-7. PubMed ID: 8093221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection.
    Marlin SD; Staunton DE; Springer TA; Stratowa C; Sommergruber W; Merluzzi VJ
    Nature; 1990 Mar; 344(6261):70-2. PubMed ID: 1968231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domains 1 and 2 of ICAM-1 are sufficient to bind human rhinoviruses.
    Lineberger DW; Uncapher CR; Graham DJ; Colonno RJ
    Virus Res; 1992 Jul; 24(2):173-86. PubMed ID: 1356290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of the two amino-terminal domains of human intercellular adhesion molecule-1 suggests how it functions as a rhinovirus receptor.
    Bella J; Kolatkar PR; Marlor CW; Greve JM; Rossmann MG
    Virus Res; 1999 Aug; 62(2):107-17. PubMed ID: 10507321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.
    Staunton DE; Gaur A; Chan PY; Springer TA
    J Immunol; 1992 May; 148(10):3271-4. PubMed ID: 1349619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1.
    McClelland A; deBear J; Yost SC; Meyer AM; Marlor CW; Greve JM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7993-7. PubMed ID: 1716769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus.
    Ockenhouse CF; Betageri R; Springer TA; Staunton DE
    Cell; 1992 Jan; 68(1):63-9. PubMed ID: 1346257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released.
    Casasnovas JM; Springer TA
    J Virol; 1994 Sep; 68(9):5882-9. PubMed ID: 7914550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of the Kilifi mutation in the rhinovirus-binding domain of ICAM-1 in a Caucasian population.
    Vijgen L; Van Essche M; Van Ranst M
    Genet Test; 2003; 7(2):159-61. PubMed ID: 12885341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional studies of truncated soluble intercellular adhesion molecule 1 expressed in Escherichia coli.
    Martin S; Martin A; Staunton DE; Springer TA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1278-84. PubMed ID: 8101071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta.
    Terajima M; Yamaya M; Sekizawa K; Okinaga S; Suzuki T; Yamada N; Nakayama K; Ohrui T; Oshima T; Numazaki Y; Sasaki H
    Am J Physiol; 1997 Oct; 273(4):L749-59. PubMed ID: 9357849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of ICAM-1 by major group rhinoviruses activates the LFA-1/ICAM-3 cell adhesion pathway in mononuclear phagocytes.
    Kirchberger S; Vetr H; Majdic O; Stockinger H; Stöckl J
    Immunobiology; 2006; 211(6-8):537-47. PubMed ID: 16920492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of human rhinovirus infection by multivalent fab molecules directed against ICAM-1.
    Charles CH; Luo GX; Kohlstaedt LA; Morantte IG; Gorfain E; Cao L; Williams JH; Fang F
    Antimicrob Agents Chemother; 2003 May; 47(5):1503-8. PubMed ID: 12709314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.